In an article published in Malaria Journal, members of the WWARN Molecular Scientific and Informatics Group describe the development of WWARN’s ACT Partner Drug Molecular Surveyor. Launched in 2015, this online mapping tool supports the malaria community to track over nearly 20 years the prevalence of the molecular markers that are associated with antimalarial drug resistance.
